Olink Seeks a Piece of the Protein-Array Market with Proximity Ligation Technology | GenomeWeb

Olink Bioscience, a small Swedish startup with a novel technology, has set its sights on the already crowded protein array market. Based on a technology that captures proteins in solution, rather than on a chip, and uses DNA as a reporter signal, the company promises higher sensitivity, better specificity, and more multiplexing capabilities than competitors’ products.

But it remains to be seen whether Olink will be able to capture a significant portion of the research or diagnostic market.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.